Concepedia

Victoria Copeland

VC

Statistics

Publications

10

Citations

326

H-Index

10

Active since

2011

Affiliations

University of California, Los Angeles(Current)

Eli Lilly (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Houston

Victoria Copeland is an author at University of California, Los Angeles specializing in medicine, social work, and immunology.

ORCID

Top concepts

Publications per year

2011–2023

10

Publications

10

Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors

Matthew D. Hellmann, Nicoletta Bivi, Boris Calderón et al. · Clinical Cancer Research · 2021 · 106 citations · Full text

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Sita Awasthi, John W. Balliet, Jessica A. Flynn et al. · Journal of Virology · 2013 · 50 citations · Full text

, , +14

Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris

Juergen H. Nett, Sujatha Gomathinayagam, Stephen R. Hamilton et al. · Journal of Biotechnology · 2011 · 38 citations

, , +10

Administrative Burdens in Child Welfare Systems

Frank Edwards, Kelley Fong, Victoria Copeland et al. · RSF The Russell Sage Foundation Journal of the Social Sciences · 2023 · 29 citations · Full text

Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure

Petra Verdino, Stacey L. Lee, Fariba N. Cooper et al. · British Journal of Pharmacology · 2023 · 25 citations · Full text

1–5 of 10